Apellis Pharmaceuticals Announces That APL-2 Met Its Primary Endpoint in a Phase 2 Study in Patients with Geographic Atrophy, an Advanced Form of Age-...
August 24, 2017
MaxCyte, Inc. - First Day of Dealings on AIM
March 30, 2016
Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
November 8, 2017
Apellis Pharmaceuticals Named 2012 Hot Dozen Company
October 12, 2012
12 of the Hottest Early Stage Companies in Louisville Debuted Last Night at 21c
Louisville, Kentucky - Apellis Pharmaceuticals has been named a 2012 Hot Dozen company by Greater Louisville Inc.’s EnterpriseCorp. The Hot Dozen is an annual celebration of 12 companies who have benefited from Louisville’s entrepreneurial atmosphere and continue to flourish in our region. The companies represent the cutting edge of innovation and entrepreneurship in Louisville’s business community.
Honoring them is part of EnterpriseCorp’s mission to create a new culture of entrepreneurship, provide strategic and network solutions that help client companies realize their full potential and dramatically increase the number and quality of fast-growth, entrepreneurial companies headquartered in our region.
“Being a part of the Hot Dozen is a true honor these are the companies with big picture thinking that are shaping the landscape of Louisville,” said Bobby Ferreri, EnterpriseCorp Executive Director, we look forward to their next steps and continued success.”
The company was honored in an event held last night at 21c Museum Hotel and sponsored by Hilliard Lyons. Apellis is proud to have the Hot Dozen distinction and enjoy the opportunity to be a part of the thriving entrepreneurial community of Greater Louisville.
EnterpriseCorp is the entrepreneurship-development arm of Greater Louisville Inc. EnterpriseCorp provides community, education, and fund raising assistance to entrepreneurs and companies in the Greater Louisville region. For more information on EnterpriseCorp, visit www.EnterpriseCorp.com.